HOME > News Releases

News Releases

2014.10.20
Products
PDF/101KB
Announcement of termination of co-promotion of anti-depressant, Paxil CR Tablets
2014.10.01
Corporate
PDF/88KB
Sunovion Pharmaceuticals Inc. to Divest Xopenex (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc.
2014.09.30
Licensing
PDF/107KB
Sumitomo Dainippon Pharma Acquires Patent License from DNAVEC On Clinical-grade iPS Cell Production Technology
2014.09.26
Licensing
PDF/102KB
Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America With Respect to SB623, a Therapy for Stroke
2014.08.29
Corporate
PDF/113KB
Sumitomo Dainippon Pharma Announces Transfer of Certain Fixed Assets
2014.08.21
Products
PDF/202KB
Latuda (lurasidone), a New Atypical Antipsychotic Agent for Adults with Schizophrenia, Now Available in the UK, Offers a Combination of Efficacy with Tolerability
More News Releases

Page Top